Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kronos Worldwide, Inc. (KRO) Earnings: An Early Look

Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report, and Kronos Worldwide, Inc. (NYSE:KRO) is about to release its quarterly earnings report. The key to making smart investment decisions with stocks releasing their quarter reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed, knee-jerk reaction to news that turns out to be exactly the wrong move.

As a specialty chemical maker, Kronos Worldwide, Inc. (NYSE:KRO) is highly sensitive to the price of a single specialized pigment. Will the recovery in the housing market help boost demand for the company’s products? Let’s take an early look at what’s been happening with Kronos Worldwide, Inc. (NYSE:KRO) over the past quarter and what we’re likely to see in its quarterly report on Wednesday.

Stats on Kronos

Analyst EPS Estimate ($0.05)
Year-Ago EPS $0.74
Revenue Estimate $397.8 million
Change From Year-Ago Revenue (9.1%)
Earnings Beats in Past 4 Quarters 4

Source: Yahoo! Finance.

Will Kronos look more colorful this quarter?
Analysts have gotten more pessimistic about Kronos Worldwide, Inc. (NYSE:KRO) in recent months, worsening their consensus loss estimate for the just-ended quarter by $0.03 per share and lopping nearly $0.30 per share off their 2013 full-year projections. Still, investors haven’t been that dour in their views, with the stock having risen more than 10% since early December.

E I Du Pont De Nemours And Co (NYSE:DD)Kronos Worldwide, Inc. (NYSE:KRO) is one of a select group of chemical companies that make titanium dioxide, a pigment used in paint and other coatings. E I Du Pont De Nemours And Co (NYSE:DD) is the leader in world TiO2 production, but Kronos is among the top producers as well.

But times have been tough lately for Kronos Worldwide, Inc. (NYSE:KRO), as high prices for TiO2 have sapped demand. Sherwin-Williams Company (NYSE:SHW) and other paint manufacturers put off purchases and started developing alternatives to TiO2 to try to boost their profits and, as a result, both Kronos and rival Huntsman Corporation (NYSE:HUN) said last year that margins would see pressure from falling TiO2 prices.

The question for Kronos going forward is whether a recovery in housing will boost paint demand and therefore improve the TiO2 pricing situation. Many companies in housing-related industries have already seen impressive gains due to the rebound, and Kronos could definitely benefit from better conditions in its key market.

In its quarterly results, watch for Kronos Worldwide, Inc. (NYSE:KRO) to discuss whether its February price increase has started to reverse the troubling trend of weak TiO2 pricing. With the company having raised its prices for titanium dioxide products by about $200 to $250 per metric ton, Kronos could see at least some of its profits restored in future quarters.

The article Kronos Earnings: An Early Look originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Sherwin-Williams.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!